Application | Comment | Organism |
---|---|---|
medicine | serum matrilysin level predicts recurrence in curatively resected colorectal cancer patients. Patients with matrilysin level higher than the median 4.3 ng/ml are more likely to relapse. Median time to progression in relapsed patients is 8 months if matrilysin is above 4.3 ng/ml and 18 months if matrilysin is below 4.3 ng/ml. Node-negative patients with low matrilysin level have a predicted probability of relapse-free survival at 4 years of 88%; if the matrilysin level is higher than the median value, this probability is 77% | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | P09237 | curatively resected colorectal cancer patients | - |
Source Tissue | Comment | Organism | Textmining |
---|